TY - JOUR
T1 - Genomic structures of SCN2A and SCN3A - Candidate genes for deafness at the DFNA16 locus
AU - Kasai, Norio
AU - Fukushima, Kunihiro
AU - Ueki, Yasuyoshi
AU - Prasad, Sai
AU - Nosakowski, Jennifer
AU - Sugata, Ken Ichi
AU - Sugata, Akemi
AU - Nishizaki, Kazunori
AU - Meyer, Nicole C.
AU - Smith, Richard J.H.
N1 - Funding Information:
The authors would like to thank the family described whose interest and participation made this work possible. This research is partly supported by a grant from Ministry of Health and Welfare of Japan and from Ministry of Education, Science and Culture of Japan (KF). RJHS is supported in part by RO1-DC03544.
PY - 2001/2/7
Y1 - 2001/2/7
N2 - DFNA16 is a form of autosomal dominant non-syndromic hearing loss (ADNSHL) characterized by fluctuating progressive hearing impairment. Earlier, we mapped the deafness-causing gene to chromosome 2q23-24.3. In this paper, we describe fine mapping results using additional markers tightly linked to the DFNA16 candidate region. Critical recombinants at markers D2S354 and D2S124 define a 3.5-cM interval that contains the DFNA16 gene. Positional candidate genes include two members of the voltage-gated sodium channel family, the type 2 α subunit (SCN2A) and the type 3 α subunit (SCN3A). After showing that SCN2A is expressed in human fetal cochlea, we determined its genomic structure to facilitate mutation screening in our DFNA16 kindred. We also determined the genomic structure of SCN3A. These two genes are oriented head-to-head, with their 5′ ends separated by approximately 40 kb; their homology is 82% at the nucleotide level, and 85% for identities and 90% for positives at the amino acid level. They share similar genomic structures and have alternative splice isoforms that are developmentally regulated and highly conserved between species. Although no DFNA16-causing mutations were found in either gene, haplotype analysis with polymorphic markers in SCN2A introns further narrowed the candidate gene interval to the region flanked by D2S354 and STS SHGC-82894.
AB - DFNA16 is a form of autosomal dominant non-syndromic hearing loss (ADNSHL) characterized by fluctuating progressive hearing impairment. Earlier, we mapped the deafness-causing gene to chromosome 2q23-24.3. In this paper, we describe fine mapping results using additional markers tightly linked to the DFNA16 candidate region. Critical recombinants at markers D2S354 and D2S124 define a 3.5-cM interval that contains the DFNA16 gene. Positional candidate genes include two members of the voltage-gated sodium channel family, the type 2 α subunit (SCN2A) and the type 3 α subunit (SCN3A). After showing that SCN2A is expressed in human fetal cochlea, we determined its genomic structure to facilitate mutation screening in our DFNA16 kindred. We also determined the genomic structure of SCN3A. These two genes are oriented head-to-head, with their 5′ ends separated by approximately 40 kb; their homology is 82% at the nucleotide level, and 85% for identities and 90% for positives at the amino acid level. They share similar genomic structures and have alternative splice isoforms that are developmentally regulated and highly conserved between species. Although no DFNA16-causing mutations were found in either gene, haplotype analysis with polymorphic markers in SCN2A introns further narrowed the candidate gene interval to the region flanked by D2S354 and STS SHGC-82894.
KW - Autosomal dominant non-syndromic hearing loss
KW - DFNA16
KW - SCN2A
KW - SCN3A
UR - http://www.scopus.com/inward/record.url?scp=0035819540&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035819540&partnerID=8YFLogxK
U2 - 10.1016/S0378-1119(00)00594-1
DO - 10.1016/S0378-1119(00)00594-1
M3 - Article
C2 - 11245985
AN - SCOPUS:0035819540
SN - 0378-1119
VL - 264
SP - 113
EP - 122
JO - Gene
JF - Gene
IS - 1
ER -